BERKELEY, Calif.--(BUSINESS WIRE)--Plexxikon Inc., today announced that key clinical data related to PLX4032 will be presented in an oral presentation at the ECCO 15 / ESMO 34 2009 Congress. The European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO) Joint Multidisciplinary Congress will be held in Berlin, Germany from September 20-24.
